Regeneron hosted a celebration to recognize the achievements of the 17 students selected as the Westchester 2025 Regeneron Science Talent Search Scholars. Beginning in 1942, the contest […] ...

Regeneron stock rose early Tuesday on a strong fourth-quarter report that included in-line sales of eye drug Eylea.

Jeff Stein covers economic policy at the White House ... who spoke on the condition of anonymity to describe private talks. David A. Lebryk, who served in nonpolitical roles at Treasury for ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other S&P 500 stocks. 2024 was a memorable year for the broad market index ...

With the announcement that the great David Lynch died on January 16, the world hasn’t just lost one of its greatest filmmakers: It’s lost one of its greatest artists, period. The work of a ...

David Benavidez earned arguably the biggest win of his career with his unanimous decision victory over the previously undefeated David Morrell. With the win, Benavidez (30-0, 24 KOs) is now the ...

Using CytomX’s Probody and Regeneron’s Veloci-Bi platforms, the collaboration and licensing agreement aims to enable the development of investigational next-generation bispecific immunotherapies.

Regeneron has signed a collaboration deal potentially worth $1 billion with RNAi experts Alnylam Pharmaceuticals, to develop and commercialise drugs targeting eye, central nervous system (CNS ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...

TV Chef Rick Stein has revealed he feels "a bit sorry" for Gregg Wallace, saying it would "affect me terribly" if he found himself in a similar situation. His comments come after the 60-year-old ...

Regeneron also said it was discontinuing a phase 3 study of REGN1908-1909, a multi-antibody therapy to Fel d 1 being studied as a treatment for cat allergy, due to futility. Image Phil Taylor ...